MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences